Sign up to save your podcasts
Or
Share E28-Brolucizumab for wet AMD (HAWK and HARRIER)- Dr. Pravin Dugel
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E28-Brolucizumab for wet AMD (HAWK and HARRIER)- Dr. Pravin Dugel
Dr. Dugel discusses 1 and 2 year results of HAWK and HARRIER on Brolucizumab for neovascular AMD.
Full reference:
Dugel, P. U., Koh, A., Ogura, Y., Jaffe, G. J., Schmidt-Erfurth, U., Brown, D. M., . . . Investigators, H. S. (2019). HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology. doi:10.1016/j.ophtha.2019.04.017
View all episodes
By Keyvan Koushan, MD, FRCSC
4.4
1111 ratings
Dr. Dugel discusses 1 and 2 year results of HAWK and HARRIER on Brolucizumab for neovascular AMD.
Full reference:
Dugel, P. U., Koh, A., Ogura, Y., Jaffe, G. J., Schmidt-Erfurth, U., Brown, D. M., . . . Investigators, H. S. (2019). HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology. doi:10.1016/j.ophtha.2019.04.017
More shows like The Retina Channel Podcast
View all
Ophthalmology off the Grid by Eyetube
43 Listeners
New Retina Radio by Eyetube
18 Listeners
Straight From The Cutter's Mouth: A Retina Podcast
97 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
MedEdTalks - Ophthalmology
4 Listeners
Retina Synthesis
8 Listeners
Headlight in the fog: The Uveitis Podcast
22 Listeners
Experts InSight
52 Listeners
RETINA Journal Podcasts
10 Listeners
Cataract Coach with Uday Devgan MD
16 Listeners
Ophthalmology Journal
18 Listeners
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
0 Listeners
Talking Euretina
1 Listeners
Mayo Clinic Ophthalmology Podcast
19 Listeners
RetinaRounds™
0 Listeners